Immunogenicity of renal microvascular endothelial cells from genetically modified pigs

Zheng Yu Wang, Ping Li, James R. Butler, Ross L. Blankenship, Susan M. Downey, Jessica B. Montgomery, Shunji Nagai, Jose L. Estrada, Matthew F. Tector, A. Joseph Tector

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background. Disrupting the porcine GGTA1 and CMAH genes [double knockout (DKO)] that produce the gal-á(1,3)-gal and N-glycolylneuraminic acid xenoantigens reduces human antibody binding to porcine peripheral bloodmononuclear cells. It is important to examine rejection pathways at an organ-specific level. The object of this study is to evaluate the human preformed antibody reactivity against DKOrenalmicrovascular endothelial cells (RMEC) in vitro.Methods. Characteristics of DKO RMEC were analyzed using flow cytometry. Human IgG/M binding to primary RMEC, immortalized RMEC (iRMEC), and iRMEC-deficient in B4GALNT2 genes were examined using flow cytometric crossmatch assay. Results. Porcine RMEC expressed gal-á(1,3)-gal, N-glycolylneuraminic acid, and Dolichos biflorus agglutinin glycans recognized by human preexisting antibodies in humans. Antigenicity of DKO RMEC was lower than GGTA1 KO RMEC. The disruption of B4GALNT2 gene in DKO iRMEC further reduced human IgG/IgM binding. Conclusions. Silencing the porcine GGTA1, CMAH, and B4GALNT2 genes is an effective strategy to reduce human preformed antibody binding to RMEC. Porcine RMEC will be a useful reagent for the further study of xenoimmunology.

Original languageEnglish (US)
Pages (from-to)533-537
Number of pages5
JournalTransplantation
Volume100
Issue number3
DOIs
StatePublished - 2016

Fingerprint

Swine
Endothelial Cells
Kidney
Antibodies
Immunoglobulin G
Heterophile Antigens
Genes
Gene Knockout Techniques
Polysaccharides
Immunoglobulin M
Flow Cytometry
galactosyl-(1-3)galactose
N-glycolylneuraminic acid

ASJC Scopus subject areas

  • Transplantation

Cite this

Wang, Z. Y., Li, P., Butler, J. R., Blankenship, R. L., Downey, S. M., Montgomery, J. B., ... Joseph Tector, A. (2016). Immunogenicity of renal microvascular endothelial cells from genetically modified pigs. Transplantation, 100(3), 533-537. https://doi.org/10.1097/TP.0000000000001070

Immunogenicity of renal microvascular endothelial cells from genetically modified pigs. / Wang, Zheng Yu; Li, Ping; Butler, James R.; Blankenship, Ross L.; Downey, Susan M.; Montgomery, Jessica B.; Nagai, Shunji; Estrada, Jose L.; Tector, Matthew F.; Joseph Tector, A.

In: Transplantation, Vol. 100, No. 3, 2016, p. 533-537.

Research output: Contribution to journalArticle

Wang, ZY, Li, P, Butler, JR, Blankenship, RL, Downey, SM, Montgomery, JB, Nagai, S, Estrada, JL, Tector, MF & Joseph Tector, A 2016, 'Immunogenicity of renal microvascular endothelial cells from genetically modified pigs', Transplantation, vol. 100, no. 3, pp. 533-537. https://doi.org/10.1097/TP.0000000000001070
Wang ZY, Li P, Butler JR, Blankenship RL, Downey SM, Montgomery JB et al. Immunogenicity of renal microvascular endothelial cells from genetically modified pigs. Transplantation. 2016;100(3):533-537. https://doi.org/10.1097/TP.0000000000001070
Wang, Zheng Yu ; Li, Ping ; Butler, James R. ; Blankenship, Ross L. ; Downey, Susan M. ; Montgomery, Jessica B. ; Nagai, Shunji ; Estrada, Jose L. ; Tector, Matthew F. ; Joseph Tector, A. / Immunogenicity of renal microvascular endothelial cells from genetically modified pigs. In: Transplantation. 2016 ; Vol. 100, No. 3. pp. 533-537.
@article{bf39f59b67104433905db34f94de3922,
title = "Immunogenicity of renal microvascular endothelial cells from genetically modified pigs",
abstract = "Background. Disrupting the porcine GGTA1 and CMAH genes [double knockout (DKO)] that produce the gal-{\'a}(1,3)-gal and N-glycolylneuraminic acid xenoantigens reduces human antibody binding to porcine peripheral bloodmononuclear cells. It is important to examine rejection pathways at an organ-specific level. The object of this study is to evaluate the human preformed antibody reactivity against DKOrenalmicrovascular endothelial cells (RMEC) in vitro.Methods. Characteristics of DKO RMEC were analyzed using flow cytometry. Human IgG/M binding to primary RMEC, immortalized RMEC (iRMEC), and iRMEC-deficient in B4GALNT2 genes were examined using flow cytometric crossmatch assay. Results. Porcine RMEC expressed gal-{\'a}(1,3)-gal, N-glycolylneuraminic acid, and Dolichos biflorus agglutinin glycans recognized by human preexisting antibodies in humans. Antigenicity of DKO RMEC was lower than GGTA1 KO RMEC. The disruption of B4GALNT2 gene in DKO iRMEC further reduced human IgG/IgM binding. Conclusions. Silencing the porcine GGTA1, CMAH, and B4GALNT2 genes is an effective strategy to reduce human preformed antibody binding to RMEC. Porcine RMEC will be a useful reagent for the further study of xenoimmunology.",
author = "Wang, {Zheng Yu} and Ping Li and Butler, {James R.} and Blankenship, {Ross L.} and Downey, {Susan M.} and Montgomery, {Jessica B.} and Shunji Nagai and Estrada, {Jose L.} and Tector, {Matthew F.} and {Joseph Tector}, A.",
year = "2016",
doi = "10.1097/TP.0000000000001070",
language = "English (US)",
volume = "100",
pages = "533--537",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Immunogenicity of renal microvascular endothelial cells from genetically modified pigs

AU - Wang, Zheng Yu

AU - Li, Ping

AU - Butler, James R.

AU - Blankenship, Ross L.

AU - Downey, Susan M.

AU - Montgomery, Jessica B.

AU - Nagai, Shunji

AU - Estrada, Jose L.

AU - Tector, Matthew F.

AU - Joseph Tector, A.

PY - 2016

Y1 - 2016

N2 - Background. Disrupting the porcine GGTA1 and CMAH genes [double knockout (DKO)] that produce the gal-á(1,3)-gal and N-glycolylneuraminic acid xenoantigens reduces human antibody binding to porcine peripheral bloodmononuclear cells. It is important to examine rejection pathways at an organ-specific level. The object of this study is to evaluate the human preformed antibody reactivity against DKOrenalmicrovascular endothelial cells (RMEC) in vitro.Methods. Characteristics of DKO RMEC were analyzed using flow cytometry. Human IgG/M binding to primary RMEC, immortalized RMEC (iRMEC), and iRMEC-deficient in B4GALNT2 genes were examined using flow cytometric crossmatch assay. Results. Porcine RMEC expressed gal-á(1,3)-gal, N-glycolylneuraminic acid, and Dolichos biflorus agglutinin glycans recognized by human preexisting antibodies in humans. Antigenicity of DKO RMEC was lower than GGTA1 KO RMEC. The disruption of B4GALNT2 gene in DKO iRMEC further reduced human IgG/IgM binding. Conclusions. Silencing the porcine GGTA1, CMAH, and B4GALNT2 genes is an effective strategy to reduce human preformed antibody binding to RMEC. Porcine RMEC will be a useful reagent for the further study of xenoimmunology.

AB - Background. Disrupting the porcine GGTA1 and CMAH genes [double knockout (DKO)] that produce the gal-á(1,3)-gal and N-glycolylneuraminic acid xenoantigens reduces human antibody binding to porcine peripheral bloodmononuclear cells. It is important to examine rejection pathways at an organ-specific level. The object of this study is to evaluate the human preformed antibody reactivity against DKOrenalmicrovascular endothelial cells (RMEC) in vitro.Methods. Characteristics of DKO RMEC were analyzed using flow cytometry. Human IgG/M binding to primary RMEC, immortalized RMEC (iRMEC), and iRMEC-deficient in B4GALNT2 genes were examined using flow cytometric crossmatch assay. Results. Porcine RMEC expressed gal-á(1,3)-gal, N-glycolylneuraminic acid, and Dolichos biflorus agglutinin glycans recognized by human preexisting antibodies in humans. Antigenicity of DKO RMEC was lower than GGTA1 KO RMEC. The disruption of B4GALNT2 gene in DKO iRMEC further reduced human IgG/IgM binding. Conclusions. Silencing the porcine GGTA1, CMAH, and B4GALNT2 genes is an effective strategy to reduce human preformed antibody binding to RMEC. Porcine RMEC will be a useful reagent for the further study of xenoimmunology.

UR - http://www.scopus.com/inward/record.url?scp=84959934784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959934784&partnerID=8YFLogxK

U2 - 10.1097/TP.0000000000001070

DO - 10.1097/TP.0000000000001070

M3 - Article

C2 - 26906938

AN - SCOPUS:84959934784

VL - 100

SP - 533

EP - 537

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 3

ER -